Surface modification of permalloy (Ni₈₀Fe₂₀) nanoparticles for biomedical applications

We report a simple and novel method for surface biofunctionalization onto recently reported Ni₈₀Fe₂₀ permalloy nanoparticles (~71 nm) and the immobilization of a model protein, IgG from human serum. The strategy of protein immobilization involved attachment of histidine-tagged streptavidin to the Ni₈₀Fe₂₀ nanoparticles via a non-covalent ligand binding followed by biotinylated human IgG binding on the nanoparticle surface using the specific high affinity avidin–biotin interaction. The biofunctionalization of Ni₈₀Fe₂₀ permalloy nanoparticles was confirmed by Fourier Transform InfraRed (FTIR) spectroscopy and protein denaturing gel electrophoresis (lithium dodecyl sulfate-polyacrylamide gel electrophoresis, LDS-PAGE). This protocol for surface functionalization of the novel nanometer-sized Ni₈₀Fe₂₀ permalloy particles with biological molecules could open diverse applications in disease diagnostics and drug delivery.